Cardiovascular disease continues to be an ever-growing global health issue and remains the leading cause of death worldwide. And while it is a preventable disease, developing new methods and technologies to investigate and fight this disease remains a top priority. Regardless of what stage your research is in, Charles River’s comprehensive portfolio of products and services provides you with the necessary resources to advance your work. Basic Research Cardiovascular Disease Models Surgically Altered Models Preconditioned Models Device Implants Operations & Staffing Support Drug Discovery Anti-Atherosclerotic Drug Efficacy Studies Discovery Pathology Biomarker & Analytical Services Safety Assessment Safety Pharmacology Studies Toxicology Studies IND Programs Pathology Services Drug Metabolism & Pharmacokinetics Laboratory Sciences Clinical Support Clinical Bioanalysis Clinical Pharmacokinetics Clinical Immunology & Biomarker Services Pathology for Clinical Trials Manufacturing Support GMP-Compliant Biopharmaceutical Manufacturing Endotoxin Detection & Microbial Identification